Delivery Order SPE2DB25D3002-SPE2DB26FLPKY
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $51,571.36 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 (60-count units), a combination inhalation medication used in respiratory disease management. This firm fixed price delivery order, issued on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a non-set-aside competitive award. The contract was performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $18,103.28 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 inhaler, a combination respiratory medication used to treat chronic obstructive pulmonary disease. This firm fixed price delivery order was awarded on August 12, 2025, with an ultimate completion date of August 13, 2025, and represents a non-competitive award under the company's existing contract vehicle. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count), with a ceiling value of $4,436.68 and an ultimate completion date of October 31, 2025. This non-set-aside, firm fixed-price delivery order represents a small-value pharmaceutical procurement under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a delivery order valued at $5,773.90 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count) on August 5, 2025, with completion scheduled for August 6, 2025. This firm fixed-price delivery order, issued without a set-aside designation, represents a competitively awarded transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $13,073.07 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 inhalers (60-count), a combination respiratory medication used to treat chronic obstructive pulmonary disease. This firm fixed-price, competitively awarded delivery order was issued on November 6, 2025, with a completion date of November 7, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The contract carries no...
- The Defense Logistics Agency awarded a delivery order valued at $3,415.62 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 inhalers (60-count units) on July 14, 2025, with completion expected by July 15, 2025. This firm fixed price delivery order represents a non-competitive award under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999.999 billion through December 2026. The product is being delivered to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units) with a ceiling value of $1,089.41. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement process. The order is set to reach completion by November 4, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $1,817.91 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 inhalers (60-count package), a combination respiratory medication used to treat chronic obstructive pulmonary disease. This firm fixed-price delivery order was competitively awarded without set-aside restrictions and is scheduled for completion by November 10, 2025. The contract will be fulfilled from AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $13,758.08 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 inhalers (60-count supply) on November 5, 2025, with completion scheduled for November 6, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under AmerisourceBergen's existing contract vehicle. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This award...
- The Defense Logistics Agency awarded a delivery order valued at $3,961.34 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25 inhalers (60-count units). This is a firm fixed-price delivery order with no set-aside designation, issued on September 17, 2025, with an ultimate completion date of September 18, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office and primary operations. This delivery order...
- SPE2DB25D3002Indefinite Delivery Contract
- SPE2DB25D3002-SPE2DB26FLPKYDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,331.47 to AmerisourceBergen Drug Corp for Trelegy Ellipta 200-62.5-25 (60-count inhalers), a combination respiratory medication used to treat chronic obstructive pulmonary disease. This non-competitive delivery order, issued on November 10, 2025, with completion expected by November 12, 2025, represents a firm fixed-price pharmaceutical supply transaction. The award was fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters as a major pharmaceutical distributor serving federal healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle provides comprehensive pharmaceutical and medical supply support to military healthcare programs globally, enabling the company to supply medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic areas to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare entities. AmerisourceBergen's extensive federal contract portfolio demonstrates its critical role in supporting military medical supply chain operations through competitive procurement practices.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 11/10/25 |